To understand the clinical relevance of these findings, we have used the publicly available Kaplan–Meier plotter portal (18) dataset to determine the impact of fascin coexpression with β-catenin transcriptional genes on breast cancer recurrence-free survival (RFS; n = 3,951). The gene discussed is FSCN1; the disease is breast carcinoma.